Wangbin Zhou's Stock Coverage
| 1672Ascletis Pharma, Inc. | Feb 03, 2026 | BUY | Reiterated | HK$32.00 | 2Ratings | -42.75% | ||
| 1801Innovent Biologics | Aug 28, 2025 | BUY | Reiterated | HK$110.00 | 2Ratings | +13.50% | ||
| 6990Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H | Aug 20, 2025 | BUY | Reiterated | HK$560.00 | 1Ratings | +23.60% | ||
| 0013HUTCHMED (China) | Aug 11, 2025 | BUY | Reiterated | HK$36.00 | 2Ratings | -17.90% | ||
| 9926Akeso, Inc. | Jul 28, 2025 | BUY | Reiterated | HK$185.00 | 3Ratings | +54.33% | ||
| 1877Shanghai Junshi Biosciences Co., Ltd. Class H | Jul 28, 2025 | BUY | Reiterated | HK$32.00 | 1Ratings | -32.10% | ||
| 15303SBio | Jul 28, 2025 | BUY | Reiterated | HK$36.00 | 2Ratings | -24.95% | ||
| 6996Antengene Corporation Limited | Jun 27, 2025 | HOLD | Downgraded | HK$3.50 | 1Ratings | ― | ― | |
| 9995RemeGen Co. Ltd. Class H | Mar 31, 2025 | BUY | Reiterated | HK$32.00 | 1Ratings | +304.20% | ||
| LEGNLegend Biotech | Mar 12, 2025 | BUY | Reiterated | $95.00 | 1Ratings | -50.10% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Wangbin Zhou activity FAQ
What is the performance of Wangbin Zhou's recommendations?
The percentage of profitable recommendations made by Wangbin Zhou is 47.06%, and the average return per transaction is 23.40%.
What stocks does Wangbin Zhou cover?
Wangbin Zhou mostly covers Ascletis Pharma, Inc., Innovent Biologics, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H stocks.
What was Wangbin Zhou's most profitable rating?
Wangbin Zhou’s most profitable rating was a buy on RemeGen Co. Ltd. Class H stock on Mar 31, 2025. The return on the trade was 304.20%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here